Effects of local treatment with salmeterol and terbutaline on anti-IgE-induced wheal, flare, and late induration in human skin
- 1 October 1996
- Vol. 51 (10), 685-692
- https://doi.org/10.1111/j.1398-9995.1996.tb02111.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of salmeterol and terbutaline on IgE‐mediated dermal reactions and inflammatory events in skin chambers in atopic patientsAllergy, 1996
- Anti-IgE–induced accumulation of leukocytes, mediators, and albumin in skin chamber fluid from healthy and atopic subjectsJournal of Allergy and Clinical Immunology, 1996
- The pharmacology of salmeterolLife Sciences, 1993
- The effect of salmeterol on the early‐ and late‐phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein XAllergy, 1993
- Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactionsClinical and Experimental Allergy, 1992
- Characterization of phospholipase A2 activity in rat RPAR-induced pleurisyInflammation Research, 1991
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- Inhibition of anti‐IgE induced skin responsein normals by formoterol, a new β2‐adrenoceptor agonist, and terbutalineAllergy, 1990
- Inhibition of anti‐IgE induced skin response in normals by formoterol, a new β2 adrenoceptor agonist, and terbutalineAllergy, 1990
- Effect of Terbutaline, a β2‐adrenergic Receptor Stimulating Compound, on Cutaneous Responses to Histamine, Allergen, Compound 48/80, and TrypsinAllergy, 1979